149 related articles for article (PubMed ID: 37216303)
21. p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.
Lund H; Nielsen S; Grove A; Vyberg M; Sunde L
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):694-701. PubMed ID: 31567274
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the vascular profile and CD99 protein expression in the partial and complete hydatidiform moles using quantitative CD34 immunohistochemistry.
Hussein MR
Exp Mol Pathol; 2010 Dec; 89(3):343-50. PubMed ID: 20630481
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
24. Hydatidiform moles: ancillary techniques to refine diagnosis.
Ronnett BM; DeScipio C; Murphy KM
Int J Gynecol Pathol; 2011 Mar; 30(2):101-16. PubMed ID: 21293291
[TBL] [Abstract][Full Text] [Related]
25. Diandric triploid hydatidiform mole with loss of maternal chromosome 11.
DeScipio C; Haley L; Beierl K; Pandit AP; Murphy KM; Ronnett BM
Am J Surg Pathol; 2011 Oct; 35(10):1586-91. PubMed ID: 21881485
[TBL] [Abstract][Full Text] [Related]
26. Comparison of p57, c-erbB-2, CD117, and Bcl-2 expression in the differential diagnosis of hydatidiform mole and hydropic abortion.
Erol O; Suren D; Tutus B; Yararbas K; Sayiner A; Ozel MK; Derbent AU; Sezer C
Eur J Gynaecol Oncol; 2016 Aug; 37(4):522-529. PubMed ID: 29894078
[TBL] [Abstract][Full Text] [Related]
27. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
28. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
[TBL] [Abstract][Full Text] [Related]
29. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F
Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104
[TBL] [Abstract][Full Text] [Related]
30. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution.
Xing D; Adams E; Zou YS; Morsberger L; Scanga LR; Gao FF; Barker N; Vang R; Ronnett BM
Am J Surg Pathol; 2022 Sep; 46(9):1180-1195. PubMed ID: 35796652
[TBL] [Abstract][Full Text] [Related]
31. Expression of leptin and leptin receptors in gestational trophoblastic diseases.
Li RH; Yu MM; Cheung AN; Wong YF
Gynecol Oncol; 2004 Nov; 95(2):299-306. PubMed ID: 15491749
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.
Erol O; Süren D; Tutuş B; Toptaş T; Gökay AA; Derbent AU; Özel MK; Sezer C
Pathol Oncol Res; 2016 Jul; 22(3):515-21. PubMed ID: 26683836
[TBL] [Abstract][Full Text] [Related]
33. Auxiliary and experimental diagnostic techniques for hydatidiform moles.
Usui H
J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274
[TBL] [Abstract][Full Text] [Related]
34. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
[TBL] [Abstract][Full Text] [Related]
35. Role of P57KIP2 Immunohistochemical Expression in Histological Diagnosis of Hydatidiform Moles.
Triratanachat S; Nakaporntham P; Tantbirojn P; Shuangshoti S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2016; 17(4):2061-6. PubMed ID: 27221896
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of p57
Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
[TBL] [Abstract][Full Text] [Related]
37. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
Yang SM; You JF; Zhang XW; Zheng J; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
[TBL] [Abstract][Full Text] [Related]
38. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
39. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of Hydatidiform Mole and Hydropic Abortion.
Maggiori MS; Peres LC
Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):170-6. PubMed ID: 17602823
[TBL] [Abstract][Full Text] [Related]
40. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
